Priority Review

Priority Review is a regulatory designation within the drug approval process that accelerates the evaluation timeline for a pharmaceutical product to address unmet medical needs or demonstrate significant therapeutic advantages over existing treatments.

78

Publications

3.6K

Citations

319

Authors

204

Institutions

Publications per year

2017–2026

34

Authors

319

  1. AS
    Aaron S. Kesselheim

    Brigham and Women's Hospital, United States

    7 publications · 761 citations

    7

    h-index

  2. TJ
    Thomas J. Hwang

    Brigham and Women's Hospital, United States

    3 publications · 132 citations

    3

    h-index

  3. DB
    David B. Ridley

    Duke University, United States

    3 publications · 84 citations

    3

    h-index

  4. JM
    Jessica M. Franklin

    Brigham and Women's Hospital, United States

    3 publications · 241 citations

    3

    h-index

  5. JJ
    Jonathan J. Darrow

    Brigham and Women's Hospital, United States

    3 publications · 633 citations

    3

    h-index

1–5 of 319

Venues

  1. JAMA

    6 publications · 659 citations

    7

    h-index

  2. BMJ Open

    5 publications · 190 citations

    5

    h-index

  3. Journal of Clinical Epidemiology

    4 publications · 139 citations

    4

    h-index

  4. Health Affairs

    4 publications · 211 citations

    4

    h-index

  5. PubMed

    Repository · 3 publications · 58 citations

    3

    h-index

1–5